Stephen M. Hahn's most recent trade in Sensei Biotherapeutics Inc was a trade of 44,763 Common Stock done . Disclosure was reported to the exchange on June 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sensei Biotherapeutics Inc | Stephen M. Hahn | Director | 12 Jun 2026 | 44,763 | 44,763 | - | - | Common Stock | ||
| Sensei Biotherapeutics Inc | Stephen M. Hahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Sensei Biotherapeutics Inc | Stephen M. Hahn | Director | 12 Jun 2026 | 44 | 0 | - | - | Series B Preferred Stock |